Cargando…

Sphingosine-1-Phosphate Catabolizing Enzymes Predict Better Prognosis in Triple-Negative Breast Cancer Patients and Correlates With Tumor-Infiltrating Immune Cells

Background: Triple-negative breast cancer (TNBC) is associated with a poor prognosis. Sphingosine-1-phosphate (S1P), a potent sphingolipid metabolite, has been implicated in many processes that are important for breast cancer (BC). S1P signaling regulates tumorigenesis, and response to chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nema, Rajeev, Kumar, Ashok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255376/ https://www.ncbi.nlm.nih.gov/pubmed/34235182 http://dx.doi.org/10.3389/fmolb.2021.697922

Ejemplares similares

New progress in the role of microRNAs in the diagnosis and prognosis of triple negative breast cancer
por: Fu, Yeqin, et al.
Publicado: (2023)

Upregulation of GNPNAT1 Predicts Poor Prognosis and Correlates With Immune Infiltration in Lung Adenocarcinoma
por: Liu, Wenting, et al.
Publicado: (2021)

Low Expression of RILPL2 Predicts Poor Prognosis and Correlates With Immune Infiltration in Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2021)

The Functional Role of Sphingosine Kinase 2
por: Diaz Escarcega, Rocio, et al.
Publicado: (2021)

Establishment of a Cell Necroptosis Index to Predict Prognosis and Drug Sensitivity for Patients With Triple-Negative Breast Cancer
por: Xie, Jindong, et al.
Publicado: (2022)

Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses
por: Green-Tripp, Gabriela, et al.
Publicado: (2022)

The application of exosomes in the treatment of triple-negative breast cancer
por: Weaver, John W., et al.
Publicado: (2022)

Current Advances on Structure-Function Relationships of Pyridoxal 5′-Phosphate-Dependent Enzymes
por: Liang, Jing, et al.
Publicado: (2019)

Overexpressed CMTM6 Improves Prognosis and Associated With Immune Infiltrates of Ovarian Cancer
por: Yin, Bo, et al.
Publicado: (2022)

Evaluation of NTRK Gene Fusion by Five Different Platforms in Triple-Negative Breast Carcinoma
por: Wu, Shafei, et al.
Publicado: (2021)

Immunotherapy in triple-negative breast cancer: Insights into tumor immune landscape and therapeutic opportunities
por: Ribeiro, Rita, et al.
Publicado: (2022)

Machine learning-driven exploration of drug therapies for triple-negative breast cancer treatment
por: Kaushik, Aman Chandra, et al.
Publicado: (2023)

Emerging role of sphingosine-1-phosphate signaling in head and neck squamous cell carcinoma
por: Nema, Rajeev, et al.
Publicado: (2016)

Deoxythymidylate Kinase as a Promising Marker for Predicting Prognosis and Immune Cell Infiltration of Pan-cancer
por: Lan, Tianfeng, et al.
Publicado: (2022)

Advances in Stem Cell Research- A Ray of Hope in Better Diagnosis and Prognosis in Neurodegenerative Diseases
por: Singh, Shripriya, et al.
Publicado: (2016)

BTBD10 is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma
por: Li, Jianhui, et al.
Publicado: (2022)

RAB42 is a Potential Biomarker that Correlates With Immune Infiltration in Hepatocellular Carcinoma
por: Peng, Hao, et al.
Publicado: (2022)

NMR-Based Metabolomics Analysis Predicts Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
por: He, Xiangming, et al.
Publicado: (2021)

Liver Kinase B1 Regulates Remodeling of the Tumor Microenvironment in Triple-Negative Breast Cancer
por: King, Connor T., et al.
Publicado: (2022)

Immune Subtypes Characterization Identifies Clinical Prognosis, Tumor Microenvironment Infiltration, and Immune Response in Ovarian Cancer
por: Lu, Weihong, et al.
Publicado: (2022)

Comprehensive Analysis on Prognosis and Immune Infiltration of Lysyl Oxidase Family Members in Pancreatic Adenocarcinoma With Experimental Verification
por: Jiang, Chao, et al.
Publicado: (2022)

Construction of a tumor immune infiltration macrophage signature for predicting prognosis and immunotherapy response in liver cancer
por: Huang, Anmin, et al.
Publicado: (2022)

ARHGAP11A Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer
por: Fan, Biao, et al.
Publicado: (2021)

YAP1 is a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Pancreatic Cancer
por: Sun, Kai, et al.
Publicado: (2021)

KIF18B is a Prognostic Biomarker and Correlates with Immune Infiltrates in Pan-Cancer
por: Qiu, Meng-jun, et al.
Publicado: (2021)

KLHL5 Is a Prognostic-Related Biomarker and Correlated With Immune Infiltrates in Gastric Cancer
por: Wu, Qiulin, et al.
Publicado: (2020)

FAT10 is a Prognostic Biomarker and Correlated With Immune Infiltrates in Skin Cutaneous Melanoma
por: Wang, Yu, et al.
Publicado: (2022)

Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancer
por: Ohotski, J, et al.
Publicado: (2012)

Prognostic Effect of Microenvironment Phenotype in Triple-Negative Breast Cancer: Biomarker Analysis of a Prospective Trial
por: Zhu, Si-Yuan, et al.
Publicado: (2021)

CRISPR/Cas9 as a therapeutic tool for triple negative breast cancer: from bench to clinics
por: Tiwari, Prashant Kumar, et al.
Publicado: (2023)

Identification of TRPM2 as a Marker Associated With Prognosis and Immune Infiltration in Kidney Renal Clear Cell Carcinoma
por: Sun, Lei, et al.
Publicado: (2022)

Comprehensive Analysis of Necroptosis-Related Long Noncoding RNA Immune Infiltration and Prediction of Prognosis in Patients With Colon Cancer
por: Liu, Li, et al.
Publicado: (2022)

Immune Cell Infiltration and Relevant Gene Signatures in the Tumor Microenvironment that Significantly Associates With the Prognosis of Patients With Breast Cancer
por: Xu, Qiang, et al.
Publicado: (2022)

Erratum: Construction of a tumor immune infiltration macrophage signature for predicting prognosis and immunotherapy response in liver cancer
por: Frontiers Production Office,
Publicado: (2022)

Sphingosine Kinase 1 Signaling in Breast Cancer: A Potential Target to Tackle Breast Cancer Stem Cells
por: Hii, Ling-Wei, et al.
Publicado: (2021)

ANTXR1 Is a Prognostic Biomarker and Correlates With Stromal and Immune Cell Infiltration in Gastric Cancer
por: Huang, Xiaodong, et al.
Publicado: (2020)

Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancer
por: Alam, Md Shahin, et al.
Publicado: (2022)

TMC5 is Highly Expressed in Human Cancers and Corelates to Prognosis and Immune Cell Infiltration: A Comprehensive Bioinformatics Analysis
por: Zhang, Hui, et al.
Publicado: (2022)

FCGR1A Serves as a Novel Biomarker and Correlates With Immune Infiltration in Four Cancer Types
por: Xu, Ji-li, et al.
Publicado: (2020)

CXCR4 is a Novel Biomarker Correlated With Malignant Transformation and Immune Infiltrates in Gastric Precancerous Lesions
por: Jiang, Xiaotao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nhe7deavl2ic208t1nqj06hb9s